Literature DB >> 33893073

Interstitial Deletions Generating Fusion Genes.

Ioannis Panagopoulos1, Sverre Heim2,3.   

Abstract

A fusion gene is the physical juxtaposition of two different genes resulting in a structure consisting of the head of one gene and the tail of the other. Gene fusion is often a primary neoplasia-inducing event in leukemias, lymphomas, solid malignancies as well as benign tumors. Knowledge about fusion genes is crucial not only for our understanding of tumorigenesis, but also for the diagnosis, prognostication, and treatment of cancer. Balanced chromosomal rearrangements, in particular translocations and inversions, are the most frequent genetic events leading to the generation of fusion genes. In the present review, we summarize the existing knowledge on chromosome deletions as a mechanism for fusion gene formation. Such deletions are mostly submicroscopic and, hence, not detected by cytogenetic analyses but by array comparative genome hybridization (aCGH) and/or high throughput sequencing (HTS). They are found across the genome in a variety of neoplasias. As tumors are increasingly analyzed using aCGH and HTS, it is likely that more interstitial deletions giving rise to fusion genes will be found, significantly impacting our understanding and treatment of cancer. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Interstitial deletion; chromosome; cytogenetics; fusion gene; review

Mesh:

Year:  2021        PMID: 33893073      PMCID: PMC8126330          DOI: 10.21873/cgp.20251

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  362 in total

Review 1.  The function of TRPS1 in the development and differentiation of bone, kidney, and hair follicles.

Authors:  Zhibo Gai; Ting Gui; Yasuteru Muragaki
Journal:  Histol Histopathol       Date:  2011-07       Impact factor: 2.303

2.  Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3.

Authors:  A Paoloni-Giacobino; H Chen; M C Peitsch; C Rossier; S E Antonarakis
Journal:  Genomics       Date:  1997-09-15       Impact factor: 5.736

3.  Clinical significance of ROS1 5' deletions in non-small cell lung cancer.

Authors:  Elisa Capizzi; Filippo Gustavo Dall'Olio; Elisa Gruppioni; Francesca Sperandi; Annalisa Altimari; Francesca Giunchi; Michelangelo Fiorentino; Andrea Ardizzoni
Journal:  Lung Cancer       Date:  2019-07-17       Impact factor: 5.705

4.  Characterization of the ros1-gene products expressed in human glioblastoma cell lines.

Authors:  S Sharma; C Birchmeier; J Nikawa; K O'Neill; L Rodgers; M Wigler
Journal:  Oncogene Res       Date:  1989

5.  Identification of NTRK fusions in pediatric mesenchymal tumors.

Authors:  Dean Pavlick; Alexa B Schrock; Denise Malicki; Philip J Stephens; Dennis J Kuo; Hyunah Ahn; Brian Turpin; Justin M Allen; Mark Rosenzweig; Kamran Badizadegan; Jeffrey S Ross; Vincent A Miller; Victor Wong; Siraj M Ali
Journal:  Pediatr Blood Cancer       Date:  2017-01-18       Impact factor: 3.167

6.  Characterization of the human and mouse HEY1, HEY2, and HEYL genes: cloning, mapping, and mutation screening of a new bHLH gene family.

Authors:  C Steidl; C Leimeister; B Klamt; M Maier; I Nanda; M Dixon; R Clarke; M Schmid; M Gessler
Journal:  Genomics       Date:  2000-06-01       Impact factor: 5.736

7.  A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer.

Authors:  Xiaoyu Qu; Grace Randhawa; Cynthia Friedman; Siobhan O'Hara-Larrivee; Kathleen Kroeger; Ruth Dumpit; Larry True; Funda Vakar-Lopez; Christopher Porter; Robert Vessella; Peter Nelson; Min Fang
Journal:  Cancer Genet       Date:  2013-01-24

8.  Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.

Authors:  Timothy A Dinh; Eva C M Vitucci; Eliane Wauthier; Rondell P Graham; Wendy A Pitman; Tsunekazu Oikawa; Mengjie Chen; Grace O Silva; Kevin G Greene; Michael S Torbenson; Lola M Reid; Praveen Sethupathy
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

9.  Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data.

Authors:  Nameeta Shah; Michael Lankerovich; Hwahyung Lee; Jae-Geun Yoon; Brett Schroeder; Greg Foltz
Journal:  BMC Genomics       Date:  2013-11-22       Impact factor: 3.969

10.  Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.

Authors:  Qingsong Gao; Wen-Wei Liang; Steven M Foltz; Gnanavel Mutharasu; Reyka G Jayasinghe; Song Cao; Wen-Wei Liao; Sheila M Reynolds; Matthew A Wyczalkowski; Lijun Yao; Lihua Yu; Sam Q Sun; Ken Chen; Alexander J Lazar; Ryan C Fields; Michael C Wendl; Brian A Van Tine; Ravi Vij; Feng Chen; Matti Nykter; Ilya Shmulevich; Li Ding
Journal:  Cell Rep       Date:  2018-04-03       Impact factor: 9.423

View more
  2 in total

1.  A Novel Cryptic t(2;3)(p21;q25) Translocation Fuses the WWTR1 and PRKCE Genes in Uterine Leiomyoma With 3q- as the Sole Visible Chromosome Abnormality.

Authors:  Ioannis Panagopoulos; Kristin Andersen; Ludmila Gorunova; Ben Davidson; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2022 Sep-Oct       Impact factor: 3.395

Review 2.  Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance.

Authors:  Suet Kee Loo; Megan E Yates; Sichun Yang; Steffi Oesterreich; Adrian V Lee; Xiao-Song Wang
Journal:  Genes Chromosomes Cancer       Date:  2022-02-17       Impact factor: 5.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.